Simvastatin attenuates endothelial dysfunction in a coronary artery-on-a-chip

View at publisher
Authors: Jasneil Singh, Deepu Ashok, Henry Howard, Steven G. Wise, Anna Waterhouse
Cited by: 1
References: 49

Abstract

) regions. Importantly, for the first time, simvastatin was found to decouple ICAM-1 expression from shear. Consequently, under dysfunctional conditions, human immune cells adhered across the chip, with spatial mapping revealing preferential adhesion at the bifurcation, which was substantially reduced by pre-treatment with simvastatin. This coronary artery-on-a-chip establishes a system to spatially map functional changes in endothelial cell behaviour in response to differential shear, geometry and drug treatment, enabling future studies into plaque initiation events and treatment targets.

Fields of Study & Subjects

3D Printing in Biomedical Research Coronary Interventions and Diagnostics Cellular Mechanics and Interactions

Publication details

Journal / source
Biomaterials Science
Publisher
Royal Society of Chemistry (RSC)
Volume
14
Issue
11
Pages
2880–2893
Publication date
1 January 2026
Language
EN